Mitchell S von Itzstein

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Venues

UT Southwestern

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UT Southwestern Jun 01 2018

United States

Resident :: Internal Medicine

Publications

Mitchell S von Itzstein, Amrit S Gonugunta, Thomas Sheffield, Jade Homsi, Jonathan E Dowell, Andrew Y Koh, Prithvi Raj, Farjana Fattah, Yiqing Wang, Vijay S Basava, Shaheen Khan, Jason Y Park, Vinita Popat, Jessica M Saltarski, Yvonne Gloria-McCutchen, David Hsiehchen, Jared Ostmeyer, Yang Xie, Quan-Zhen Li, Edward K Wakeland, David E Gerber
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy. Cancers 14 (5) (2022)
Mitchell S von Itzstein, David E Gerber, John D Minna
Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers. Cancer research 81 (13) (2021)
Mitchell S von Itzstein, Benjamin J Drapkin, John D Minna
How lung cancer cells change identity. eLife 10 (2021)
Mitchell S von Itzstein, Arjun Gupta, Kemp H Kernstine, Kristin C Mara, Sahil Khanna, David E Gerber
Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality? PloS one 15 (4) (2020)
Shaheen Khan, Mitchell S von Itzstein, Rong Lu, Bonnie L Bermas, David R Karp, Saad A Khan, Farjana J Fattah, Jason Y Park, Jessica M Saltarski, Yvonne Gloria-McCutchen, Yang Xie, Quan-Zhen Li, Edward K Wakeland, David E Gerber
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon. The oncologist 25 (5) (2020)
Mitchell S von Itzstein, Elda Railey, Mary L Smith, Carol B White, George W Sledge, John R Howell, Wendy Lawton, Donna M Marinucci, Nisha Unni, David E Gerber
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology. Cancer 126 (8) (2020)
Mitchell S von Itzstein, Rong Lu, Kemp H Kernstine, Ethan A Halm, Shidan Wang, Yang Xie, David E Gerber
Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resection. Cancer medicine 9 (12) (2020)
Mitchell S von Itzstein, Shaheen Khan, Vinita Popat, Rong Lu, Saad A Khan, Farjana J Fattah, Jason Y Park, Bonnie L Bermas, David R Karp, Murtaza Ahmed, Jessica M Saltarski, Yvonne Gloria-McCutchen, Yang Xie, Quan-Zhen Li, Edward K Wakeland, David E Gerber
Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition? The oncologist 25 (8) (2020)

Mitchell S von Itzstein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mitchell S von Itzstein